Washington, DC – The Board of Pharmacy Specialties (BPS) recently approved a practice analysis or role delineation study in Emergency Medicine Pharmacy. Conducting a role delineation study is a critical step in evaluating a proposed specialty. The purpose of the role delineation study is to determine whether this practice areas is based upon specialized knowledge of the pharmaceutical sciences, as well as specialized functions routinely performed by practitioners in the proposed specialty.

BPS is pleased to announce the members of the Practice Analysis Taskforce in Emergency Medicine Pharmacy are:

Patrick J. Bridgeman, Jr, PharmD, BCPS
Clinical Assistant Professor
Ernest Mario School of Pharmacy
Clinical Pharmacy Specialist – Emergency Medicine
Robert Wood Johnson University Hospital
New Brunswick, New Jersey

Zlatan Coralic, PharmD, BCPS
Emergency Medicine Clinical Pharmacist
UCSF Medical Center
San Francisco, California

Katelyn R. Dervay, PharmD, MPH, BCPS
Pharmacotherapy Specialist – Emergency Medicine
Tampa General Hospital
Tampa, Florida

Christopher J. Edwards, PharmD, BCPS
Senior Pharmacy Manager – Clinical Services
Banner University Medical Center Tucson
Tucson, Arizona

Kristin H. Eginger, PharmD, BCPS, BCCCP
Clinical Pharmacist: Emergency Medicine
CaroMont Regional Medical Center
Gastonia, North Carolina

A. Katie Hiles, PharmD, BCNSP
Emergency Medicine Clinical Pharmacy Specialist
Franciscan Health Indianapolis
Indianapolis, Indiana

Darrel W. Hughes, PharmD, BCPS
Clinical Specialist, Emergency Medicine
University Health System
San Antonio, Texas

Samantha P. Jellinek–Cohen, PharmD, BCPS
Emergency Medicine Clinical Pharmacy Specialist
Mount Sinai Beth Israel
New York, New York

Jennifer D. Mando–Vandrick, PharmD, BCPS
Clinical Pharmacist – Emergency Department
Duke University Hospital
Durham, North Carolina

Molly A. Mason, PharmD, BCPS, BCCCP
Clinical Pharmacy Specialist, Emergency Medicine
Eskenazi Health
Indianapolis, Indiana

Aaron L. Steffenhagen, PharmD, BCPS
Pharmacy Clinical Manager, Patient Care Services and Emergency Preparedness
UW Health-University Hospital
Madison, Wisconsin

Richard Thomas, PharmD, DABAT
Emergency Department Pharmacist
Intermountain Medical Center
Salt Lake City, Utah

Eric Villeneuve, BPharm, MSc, PharmD, BCPS
Clinical Pharmacist – Adult Emergency Medicine
McGill University Health Centre
Montreal, Quebec

Kyle A. Weant, PharmD, BCPS
Clinical Pharmacy Specialist – Emergency Medicine
Medical University of South Carolina
Charleston, South Carolina

Suprat Saely Wilson, PharmD, BCPS
Clinical Pharmacist Specialist, Emergency Medicine
Clinical Coordinator, Emergency Medicine Services
Detroit Receiving Hospital
Detroit, Michigan


The initial work of the practice analysis taskforce will be reviewed by an outside panel of subject matter experts and then validated via a survey administered to pharmacists practicing in the area. If the role delineation study in this area yields information suggestive that Emergency Medicine Pharmacy should be recognized as a specialty practice in pharmacy, BPS will then issue a call to the profession for a petition for new specialty recognition.


The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of the Board of Pharmacy Specialties is to improve patient care and increase awareness of the need for BPS Board Certified Pharmacists as integral members of multidisciplinary healthcare teams through recognition and promotion of specialized training, knowledge, and skills in pharmacy and specialty board certification and recertification of pharmacists throughout the world.

Board Certification through BPS has become recognized as the gold standard for determining which pharmacists are qualified to contribute at advanced practice levels as a result of the rigorous standards mandated by BPS board certification and recertification. Today over 30,000 pharmacists worldwide hold BPS certification.

Keith McAllister
(202) 223-7180